Docetaxel or pemetrexed with or without cetuximab in recurrent or progressive non-small-cell lung cancer after platinum-based therapy: a phase 3, open-label, randomised trial
Kim, Edward S, Prof, Neubauer, Marcus, MD, Cohn, Allen, MD, Schwartzberg, Lee, Prof, Garbo, Lawrence, MD, Caton, John, MD, Robert, Francisco, Prof, Reynolds, Craig, MD, Katz, Terry, MS, Chittoor, Sreeni, MD, Simms, Lorinda, PStat, Saxman, Scott, MD
Published in The lancet oncology (01.12.2013)
Published in The lancet oncology (01.12.2013)
Get full text
Journal Article